Miki Takenaka Sato

8PUBLICATIONS
25CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 28, 2026
Sepsis-Specific Risk Factors for Augmented Renal Clearance (ARC) and the Effect of Inflammation on Duration of ARC in Patients with Sepsis: A Single-Center Retrospective Cohort Study.

|Jul 15, 2025
Factors Associated with Initial Treatment Failure in Inpatients with Exacerbation of Chronic Obstructive Pulmonary Disease: A Cohort Study.

Noriko Kohyama, Kuniaki Hirai, Hironori Sagara

|Dec 26, 2024
Variations in serum concentrations of sunitinib and its metabolites in patients receiving long-term sunitinib treatment.

Miki Takenaka Sato, Takuya Araki, Hideaki Yashima

|Aug 28, 2024
Relationship between the combination of platelet count and neutrophil-lymphocyte ratio and prognosis of patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors plus chemotherapy: A retrospective cohort study.

Saeko Kashimura, Miki Sato, Takahito Inagaki

|Sep 12, 2023
Efficacy and safety of drug therapy for the prevention and treatment of chemotherapy-induced peripheral neuropathy: a protocol for a systematic review and network meta-analysis.

Miki Takenaka Sato, Takeshi Hasegawa, Hisashi Noma

|Nov 26, 2022
Prognostic model for overall survival that includes the combination of platelet count and neutrophil-lymphocyte ratio within the first six weeks of sunitinib treatment for metastatic renal cell carcinoma.

Miki Takenaka Sato, Ayuki Ida, Yuki Kanda

Pageof 2

Frequent Collaborators

6 joint publications

Mari Kogo

4 joint publications

Noriko Kohyama

3 joint publications

Masayuki Ohbayashi

2 joint publications

Yoshio Ogawa